| VOLUNTARY ANNOUNCEMENT -
Abbisko Therapeutics Presents Preclinical Findings on Novel Selective CDK4
Inhibitor ABSK192 in Single-Agent and Combination Studies at 2026 ENA | Nov 18, 2026 | Operations update | HKEX |
|---|
| VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING OF THE COMPANY BY THE FOUNDER,
THE EXECUTIVE DIRECTOR, THE CHIEF EXECUTIVE OFFICER AND THE CHAIRMAN OF THE BOARD OF THE COMPANY | Nov 11, 2026 | Ownership change notice | HKEX |
|---|
| INSIDE INFORMATION - PIMJETMI (pimicotinib) Receive U.S. FDA Approval for TGCT | Nov 10, 2026 | Operations update | HKEX |
|---|
| Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026 | Nov 2, 2026 | Monthly return | HKEX |
|---|
| CHANGE OF COMPANY NAME | Nov 1, 2026 | Other filings | HKEX |
|---|
| Next Day Disclosure Returns | Oct 30, 2026 | Next day disclosure return | HKEX |
|---|
| Next Day Disclosure Returns | Oct 29, 2026 | Next day disclosure return | HKEX |
|---|
| Next Day Disclosure Returns | Oct 27, 2026 | Next day disclosure return | HKEX |
|---|
| Next Day Disclosure Returns | Oct 23, 2026 | Next day disclosure return | HKEX |
|---|
| Next Day Disclosure Returns | Oct 21, 2026 | Next day disclosure return | HKEX |
|---|
| VOLUNTARY ANNOUNCEMENT -
ABBISKO THERAPEUTICS' LAVENGRATINIB (ABSK061)
FOR THE TREATMENT OF ACHONDROPLASIA GRANTED
ORPHAN DESIGNATION BY EMA | Oct 21, 2026 | Other filings | HKEX |
|---|
| Next Day Disclosure Returns | Oct 20, 2026 | Next day disclosure return | HKEX |
|---|
| Next Day Disclosure Returns | Oct 15, 2026 | Next day disclosure return | HKEX |
|---|
| Next Day Disclosure Returns | Oct 14, 2026 | Next day disclosure return | HKEX |
|---|
| Next Day Disclosure Returns | Oct 8, 2026 | Next day disclosure return | HKEX |
|---|
| Next Day Disclosure Returns | Oct 7, 2026 | Next day disclosure return | HKEX |
|---|
| Next Day Disclosure Returns | Oct 6, 2026 | Next day disclosure return | HKEX |
|---|
| Next Day Disclosure Returns | Oct 5, 2026 | Next day disclosure return | HKEX |
|---|
| Next Day Disclosure Returns | Oct 2, 2026 | Next day disclosure return | HKEX |
|---|
| Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026 | Oct 2, 2026 | Monthly return | HKEX |
|---|
| Next Day Disclosure Returns | Sep 29, 2026 | Next day disclosure return | HKEX |
|---|
| Next Day Disclosure Returns | Sep 28, 2026 | Next day disclosure return | HKEX |
|---|
| 2026 INTERIM REPORT | Sep 22, 2026 | Interim report | HKEX |
|---|
| VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS ANNOUNCES POSITIVE PRELIMINARY PHASE II RESULTS WITH LAVENGRATINIB (ABSK061) FOR THE TREATMENT OF ACHONDROPLASIA | Sep 20, 2026 | Results | HKEX |
|---|
| POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON SEPTEMBER 17, 2026 | Sep 17, 2026 | Meeting outcome | HKEX |
|---|